000 01426 a2200421 4500
005 20250517215327.0
264 0 _c20190415
008 201904s 0 0 eng d
022 _a1520-4812
024 7 _a10.1021/acs.bioconjchem.8b00223
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Huicong
245 0 0 _aMultifunctional Tumor-Targeting Cathepsin B-Sensitive Gemcitabine Prodrug Covalently Targets Albumin in Situ and Improves Cancer Therapy.
_h[electronic resource]
260 _bBioconjugate chemistry
_c06 2018
300 _a1852-1858 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCathepsin B
_xmetabolism
650 0 4 _aDeoxycytidine
_xanalogs & derivatives
650 0 4 _aDrug Delivery Systems
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProdrugs
_xchemistry
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSerum Albumin
_xmetabolism
650 0 4 _aGemcitabine
700 1 _aSun, Zhisu
700 1 _aWang, Kuanglei
700 1 _aLi, Na
700 1 _aChen, Hongxiang
700 1 _aTan, Xiao
700 1 _aLi, Lingxiao
700 1 _aHe, Zhonggui
700 1 _aSun, Jin
773 0 _tBioconjugate chemistry
_gvol. 29
_gno. 6
_gp. 1852-1858
856 4 0 _uhttps://doi.org/10.1021/acs.bioconjchem.8b00223
_zAvailable from publisher's website
999 _c28404941
_d28404941